Adelberg Laboratories, Inc., and Marvin Adelberg v. Miles, Inc.

921 F.2d 1267, 17 U.S.P.Q. 2d (BNA) 1111, 1990 U.S. App. LEXIS 21841, 1990 WL 209416
CourtCourt of Appeals for the Federal Circuit
DecidedDecember 19, 1990
Docket90-1173
StatusPublished
Cited by29 cases

This text of 921 F.2d 1267 (Adelberg Laboratories, Inc., and Marvin Adelberg v. Miles, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Adelberg Laboratories, Inc., and Marvin Adelberg v. Miles, Inc., 921 F.2d 1267, 17 U.S.P.Q. 2d (BNA) 1111, 1990 U.S. App. LEXIS 21841, 1990 WL 209416 (Fed. Cir. 1990).

Opinion

LOURIE, Circuit Judge.

Adelberg Laboratories, Inc. and Marvin Adelberg (collectively “Adelberg”) appeal the decision of the United States District Court for the Central District of California, CV 88-5798-WMB (September 25, 1989), granting defendant-appellee Miles, Incorporated’s motion for summary judgment on grounds of laches and estoppel and dismissing the patent infringement action Adel-berg brought against Miles. Since we believe that the district court did not err in concluding that there was no genuine issue as to any material fact and that defendant was entitled to judgment as a matter of law, we affirm.

BACKGROUND

In 1970, Adelberg offered Cutter Laboratories, Miles’ predecessor-in-interest, 1 a license under a pending patent application to make a roller clamp to regulate the flow of liquid through intravenous tubes used by hospitals. Cutter refused this offer. In 1971, Cutter entered into a confidential technology agreement with Abbott Laboratories. Article III, paragraph 3, of that agreement provided that:

[ejach party shall and hereby does grant to the other a nonterminable, nontransferable, worldwide, nonexclusive royalty-free license to utilize the results of any such research or development work or any inventions resulting therefrom or otherwise owned or controlled by it, in the manufacture, use and sale of intravenous solution containers, closures or administration and additive equipment ... [s]uch license shall extend to all such inventions, developments, and know-how now existing or hereafter conceived or developed by either party....

*1269 In August 1972, Adelberg was issued the original of the patent in suit, U.S. Patent 3,685,787, covering the roller clamp, 2 and in 1973, Adelberg granted Abbott an exclusive license to use and sell the patented invention. Article II of this agreement gave Abbott the right to grant sublicenses, provided that each sublicensee was subject to the same requirements as Abbott, including the obligation to pay royalties to Adelberg. The right to manufacture the patented invention was included in the license only to the extent that, if Adelberg failed to fill Abbott’s purchase orders, Abbott would automatically have obtained or could obtain a license to manufacture. Adelberg was, at this time, unaware of the technology agreement between Abbott and Cutter.

Cutter began to market its clamps in 1977. Adelberg and Abbott were both aware of the manufacture and sale of Cutter’s clamp and believed that it was covered by Adelberg’s patent. As the exclusive licensee of Adelberg, Abbott had the right to enforce the patent. Accordingly, in 1977, and later in 1978, Abbott, with the knowledge but not the participation of Adelberg, charged Cutter with infringement of the patent. Miles has asserted that Adelberg also telephoned Cutter concerning the alleged infringement in May 1977.

In September 1977, Cutter responded to Abbott that it did not believe that its clamp infringed. Cutter further told Abbott that if the patent did read on its clamp, the clamp was covered under the technology agreement between Abbott and Cutter and that Cutter was therefore entitled to a sub-license. During the period from September 1977 to January 1978, Abbott had communications with Adelberg concerning Cutter’s claim to a sublicense, indicating that Cutter was relying on the technology agreement. Adelberg thus was aware of Cutter’s position.

In November 1978, Abbott’s general counsel agreed with Cutter and told Adel-berg that if the Cutter clamp was found to be covered by the patent, Cutter would either be sublicensed or would have a right to a sublicense based on the technology agreement. Neither Abbott nor Cutter ever revealed the contents of the technology agreement to Adelberg or gave a copy of the agreement to Adelberg.

Adelberg never contacted Cutter to indicate that it did not accept Cutter’s arguments that it did not infringe or that Cutter had a right to a sublicense under the Adel-berg patent, nor did Abbott. The only contacts between Adelberg and Cutter after the 1977-78 period were two attempts by Adelberg, one in 1982 and the other in 1987, to sell clamps to Cutter.

Cutter’s sales of its own clamp grew from zero in 1977 to between seventeen and twenty million units per year in 1983, and then continued at a level of about five and a half million per year after 1983. In 1980, Cutter spent approximately $60,000 to have an additional mold built in order to increase its production capacity.

The Adelberg-Abbott exclusive license was converted to a non-exclusive license in late 1985. Then, in September 1988, ten years after the last contact between Abbott and Cutter concerning the alleged patent infringement, Adelberg filed suit for patent infringement against Miles, as successor-in-interest of Cutter, in the United States District Court for the Central District of California. Miles moved for summary judgment on the defenses of laches and estoppel and argued that the action for patent infringement should be dismissed. The district court granted Miles’ motion and dismissed the action. Adelberg appealed.

ISSUES

1. Whether the district court erred in concluding that there was no genuine issue as to any material fact with regard to Miles’ defense of laches and that Miles was entitled to judgment as a matter of law. *1270 2. Whether the district court erred in concluding that there was no genuine issue as to any material fact with regard to Miles’ defense of estoppel and that Miles was entitled to judgment as a matter of law.

DISCUSSION

A. Summary Judgment

Summary judgment is appropriate when there is no genuine issue as to any material fact and the movant is entitled to judgment as a matter of law. Fed.R.Civ.P. 56(c); Anderson v. Liberty Lobby, Inc., 477 U.S. 242, 250, 106 S.Ct. 2505, 2511, 91 L.Ed.2d 202 (1986); Jamesbury Corp. v. Litton Indus. Prods., Inc., 839 F.2d 1544, 1548, 5 USPQ2d 1779, 1782 (Fed.Cir.), cert. denied, 488 U.S. 828, 109 S.Ct. 80, 102 L.Ed.2d 57 (1988). The district court must view the evidence in the light most favorable to the nonmoving party, any doubts being resolved in favor of the party opposing the motion. The movant has the burden of demonstrating the absence of any genuine issue of material fact. Jamesbury Corp., 839 F.2d at 1548, 5 USPQ2d at 1782.

Neither party disputes the above-mentioned facts. Moreover, these facts are sufficient to permit resolution of the case. Therefore, we conclude that there is no genuine issue as to any material fact and thus that the district court did not err in so concluding. We next determine whether the court erred in concluding that Miles was entitled to judgment as a matter of law based on the established facts.

B. The Laches Defense

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Icon-IP Pty Ltd. v. Specialized Bicycle Components, Inc.
87 F. Supp. 3d 928 (N.D. California, 2015)
High Point Sarl v. Sprint Nextel Corp.
67 F. Supp. 3d 1294 (D. Kansas, 2014)
Medinol Ltd. v. Cordis Corp.
15 F. Supp. 3d 389 (S.D. New York, 2014)
Shell Global Solutions (US) Inc. v. RMS Engineering, Inc.
782 F. Supp. 2d 317 (S.D. Texas, 2011)
Lautzenhiser Technologies, LLC v. Sunrise Medical HHG, Inc.
752 F. Supp. 2d 988 (S.D. Indiana, 2010)
Plumley v. Mockett
836 F. Supp. 2d 1053 (C.D. California, 2010)
Crown Packaging Technology, Inc. v. Rexam Beverage Can Co.
498 F. Supp. 2d 718 (D. Delaware, 2007)
IXYS Corp. v. Advanced Power Technology, Inc.
321 F. Supp. 2d 1156 (N.D. California, 2004)
Vectra Fitness, Inc. v. Icon Health & Fitness, Inc.
288 F. Supp. 2d 1155 (W.D. Washington, 2003)
Altech Controls Corp. v. E.I.L. Instruments, Inc.
33 F. Supp. 2d 546 (S.D. Texas, 1998)
Scholle Corporation v. Blackhawk Molding Co., Inc.
133 F.3d 1469 (Federal Circuit, 1998)
Eastman Kodak Co. v. Goodyear Tire & Rubber Co.
114 F.3d 1547 (Federal Circuit, 1997)
CSU Holdings, Inc. v. Xerox Corp.
964 F. Supp. 1479 (D. Kansas, 1997)
In Re Independent Serv. Organ. Antitrust Lit.
964 F. Supp. 1479 (D. Kansas, 1997)
Hall Wbx v. Aqua Queen Manufacturing, Inc.
93 F.3d 1548 (Federal Circuit, 1996)
Hall v. Aqua Queen Manufacturing, Inc.
93 F.3d 1548 (Federal Circuit, 1996)

Cite This Page — Counsel Stack

Bluebook (online)
921 F.2d 1267, 17 U.S.P.Q. 2d (BNA) 1111, 1990 U.S. App. LEXIS 21841, 1990 WL 209416, Counsel Stack Legal Research, https://law.counselstack.com/opinion/adelberg-laboratories-inc-and-marvin-adelberg-v-miles-inc-cafc-1990.